The Department of Pharmacy Services has established the Eastern Carolina Drug Information Center. The Center contains extensive reference texts, drug literature files, abstracting sources, and microfilmed articles related to drugs and drug therapy. The Center offers information on topics such as drug identification, adverse reactions, interactions, pharmacokinetics, toxicity, dosing, I.V. compatibilities, pharmacology, therapeutic use, etc. This information is available to all allied health professionals. The Center, staffed by a Drug Information Specialist, is open Monday through Friday, 8:00am to 5:00pm and can be reached by dialing extension 7-4257.
The Pharmacy publishes a monthly Newsletter covering therapeutic topics and new drugs; suggestions for topics are welcomed.
Patient Medication Counseling:
Pharmacy provides discharge medication counseling to patients who have been prescribed warfarin (Coumadin). Physicians may request this service by calling the Main Pharmacy or appropriate satellite unit. Pharmacists will instruct patients as to indication for use, administration directions, potential side effects and interactions, and monitoring of therapy. In addition, reinforcing written information will be left with each counseled patient. This patient interaction will be documented in the patient’s medical record. While more limited in scope, similar counseling can be performed with other medications, as requested. Pharmacists also counsel patients on dofetilide (Tikosyn).
Antimicrobial Streamlining Program
The Pharmacy and Therapeutics Committee, in concert with the Antibiotic Utilization Stewardship Subcommittee has implemented an Antimicrobial Streamlining Program. The goals of this program are to reduce microbial resistance to antibiotics and to reduce expenditures for these medications.
The Antimicrobial Use Coordinator, a pharmacist daily reviews charts of patients receiving high use, costly and misused (Controlled) antimicrobials and makes recommendations to improve use of these medications within guidelines established by Infectious Disease physicians. Results of this Service are shared with the Antimicrobial Utilization Stewardship Subcommittee (AUSS).
This pharmacist may leave notification in the patient’s chart of the need to alter antimicrobial therapy based on culture and sensitivity data and other pertinent information that may be available at that time.
This recommendation will remain on the chart for 24 hours at which time the new therapy will be implemented - unless the primary physician for that patient indicates otherwise on the form. The reviewer will always be available to the primary physician by beeper for open discussion and for educational purposes.
March 17, 2009